The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).
 
Christina Sing-Ying Wu
Honoraria - BioTheranostics
Consulting or Advisory Role - Bayer
Research Funding - Amgen
Travel, Accommodations, Expenses - Merck
 
Terence Marques Williams
No Relationships to Disclose
 
Lai Wei
No Relationships to Disclose
 
Hamida Umar
No Relationships to Disclose
 
Sameh Mikhail
No Relationships to Disclose
 
Kristen Keon Ciombor
Research Funding - Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; MedImmune; Merck; Onyx; Pfizer
 
Emily Chan
Consulting or Advisory Role - Amgen; Bayer; EMD Serono; Lilly; Taiho Pharmaceutical
Speakers' Bureau - EMD Serono
Research Funding - Aduro Biotech; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Dekkun Corporation; Halozyme; Karyopharm Therapeutics; Merrimack; Millennium; Taiho Pharmaceutical
 
Anne M. Noonan
Consulting or Advisory Role - Helsinn Healthcare
 
Sameek Roychowdhury
No Relationships to Disclose
 
Samer S El-Dika
No Relationships to Disclose
 
Somashekar Krishna
No Relationships to Disclose
 
Sean T McCarthy
No Relationships to Disclose
 
Mark Arnold
No Relationships to Disclose
 
Alan Harzman
No Relationships to Disclose
 
Sherif Abdel-Misih
No Relationships to Disclose
 
William Cirocco
No Relationships to Disclose
 
Amber Traugott
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Regeneron; Research to Practice; Taiho Pharmaceutical
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen
 
Evan John Wuthrick
No Relationships to Disclose